ICU Map
GuidelineCurrent

EAN/PNS 2023 — European Academy of Neurology / Peripheral Nerve Society Guideline on Diagnosis and Treatment of Guillain-Barré Syndrome

EAN / PNS, 2023

Intravenous immunoglobulin (IVIG 2 g/kg total over 2–5 days) or plasma exchange (200–250 mL/kg across 5 sessions) is recommended in patients with Guillain-Barré syndrome with severe or rapidly progressive weakness. Corticosteroids alone are not effective and should not be administered.

Strong recommendationHigh certainty
View source guideline